Korea Arlico Pharm Co., Ltd. announced a private placement of round 2 non-guaranteed private equity convertible bonds with bearer type interest part for proceeds of KRW 10,000,000,000 February 11, 2022. The transaction will involve participation from Hanyang Securities Co., Ltd., Investment Arm for KRW 2,000,000,000, 'NH Absolute Return General Private Equity Trust No. 1, NH Absolute KOSDAQ Venture Mezzanine Specialized Investment Private Equity Trust No.

1, and NH Absolute KOSDAQ Venture Mezzanine Alpha General Private Equity Trust No. 1, funds managed by NH Hedge Co., Ltd. for KRW 2,000,000,000, SUSUNG ASSET MANAGEMENT Co., Ltd. for KRW 1,000,000,000 and other investors. The transaction has been approved by the board of directors of the company.

The bonds will mature on February 18, 2025. The bonds will carry zero coupon rate and maturity rate of 1%. The bonds will be convertible into 1,281,722 common shares at a conversion price of KRW 7,802.

The conversion period of the bonds will start from February 18, 2023 and end on February 18, 2025. The subscription date of the transaction is February 15, 2022 and payment date of February 18, 2022. The bond is subject to hold period of one year.